1. Home
  2. VIR vs NGL Comparison

VIR vs NGL Comparison

Compare VIR & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

HOLD

Current Price

$12.09

Market Cap

1.4B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
NGL
Founded
2016
1940
Country
United States
United States
Employees
N/A
569
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
VIR
NGL
Price
$8.40
$12.09
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.63
N/A
AVG Volume (30 Days)
3.5M
235.6K
Earning Date
05-06-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
17.49
N/A
EPS
N/A
N/A
Revenue
$68,556,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,049.62
N/A
P/E Ratio
N/A
$366.01
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$2.64
52 Week High
$10.91
$13.92

Technical Indicators

Market Signals
Indicator
VIR
NGL
Relative Strength Index (RSI) 45.05 50.02
Support Level $5.14 $11.04
Resistance Level $10.29 $13.00
Average True Range (ATR) 0.47 0.57
MACD -0.18 0.07
Stochastic Oscillator 3.20 33.66

Price Performance

Historical Comparison
VIR
NGL

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

Share on Social Networks: